Literature DB >> 22477818

The Use of Daptomycin and Linezolid to Treat Vancomycin-Intermediate Staphylococcus haemolyticus Infection in a Premature Infant.

Kalen B Porter1, Bethany Lynch, Chitra S Mani.   

Abstract

Infections with staphylococcal species, especially coagulase-negative staphylococci are common after neurosurgical procedures. We report a case of a coagulase-negative staphylococci infection of a ventricular shunt site in a 105-day-old, premature infant born at 25 weeks gestation with multiple medical problems. The patient was successfully treated with a combination of daptomycin and linezolid for the persistent infection, which was increasingly resistant to vancomycin. The patient was initially treated with a combination of vancomycin and rifampin; however, the course of therapy had to be changed when the bacteria was identified as having intermediate resistance to vancomycin. Therapy was initially changed to linezolid monotherapy, but culture results continued to be positive for the bacteria, necessitating removal of an external ventricular drain and combination therapy of daptomycin and linezolid for 2 weeks before insertion of a new ventricular shunt. The patient received 4 weeks of therapy with no further positive results of the culture analysis. To our knowledge, this is the first published case report of the use of daptomycin to successfully treat a central nervous system infection in a premature infant.

Entities:  

Year:  2010        PMID: 22477818      PMCID: PMC3042268     

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN: 1551-6776


  12 in total

1.  Treatment of cerebrospinal fluid shunt infections: a decision analysis.

Authors:  Rachel T Schreffler; Andrew J Schreffler; Robert R Wittler
Journal:  Pediatr Infect Dis J       Date:  2002-07       Impact factor: 2.129

2.  Practice guidelines for the management of bacterial meningitis.

Authors:  Allan R Tunkel; Barry J Hartman; Sheldon L Kaplan; Bruce A Kaufman; Karen L Roos; W Michael Scheld; Richard J Whitley
Journal:  Clin Infect Dis       Date:  2004-10-06       Impact factor: 9.079

3.  Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains.

Authors:  Ronny Beer; Klaus W Engelhardt; Bettina Pfausler; Gregor Broessner; Raimund Helbok; Peter Lackner; Christian Brenneis; Stefan T Kaehler; Apostolos Georgopoulos; Erich Schmutzhard
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

4.  Linezolid for treatment of catheter-related cerebrospinal fluid infections in preterm infants.

Authors:  M Langgartner; A Mutenthaler; N Haiden; A Pollak; A Berger
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2008-09       Impact factor: 5.747

5.  Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis.

Authors:  Peter Gerber; Armin Stucki; Fernando Acosta; Marianne Cottagnoud; Philippe Cottagnoud
Journal:  J Antimicrob Chemother       Date:  2006-02-03       Impact factor: 5.790

6.  Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus.

Authors:  J W Froggatt; J L Johnston; D W Galetto; G L Archer
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

7.  Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections.

Authors:  Susan M Abdel-Rahman; David P Benziger; Richard F Jacobs; Hasan S Jafri; Erica Fischer Hong; Gregory L Kearns
Journal:  Pediatr Infect Dis J       Date:  2008-04       Impact factor: 2.129

8.  Daptomycin therapy for invasive Gram-positive bacterial infections in children.

Authors:  Monica I Ardura; Asunción Mejías; Kathy S Katz; Paula Revell; George H McCracken; Pablo J Sánchez
Journal:  Pediatr Infect Dis J       Date:  2007-12       Impact factor: 2.129

9.  Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens.

Authors:  Matthew J McGirt; Aimee Zaas; Herbert E Fuchs; Timothy M George; Keith Kaye; Daniel J Sexton
Journal:  Clin Infect Dis       Date:  2003-03-18       Impact factor: 9.079

10.  In vitro activity of daptomycin against methicillin- and multi-resistant Staphylococcus haemolyticus invasive isolates carrying different mec complexes.

Authors:  Floriana Campanile; Dafne Bongiorno; Sonia Borbone; Marco Falcone; Maddalena Giannella; Mario Venditti; Stefania Stefani
Journal:  Diagn Microbiol Infect Dis       Date:  2008-03-07       Impact factor: 2.803

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.